Spinogenix

About:

Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.

Website: http://www.spinogenix.com/

Top Investors: National Institutes of Health, U.S. Department of Defense

Description:

Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases. The company is focused on regenerating synapses to reverse declines in cognitive and motor function. They envision the use of SPGs as a monotherapy or in combination with other therapeutics that target disease-specific degenerative processes. Spinogenix's mission is to create transformative therapeutics for diseases involving synaptic loss and dysfunction. It was founded in 2016 and is headquartered in San Diego, California.